Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009;47 Suppl 1(Suppl 1):S42-7.
doi: 10.5414/cpp47042.

Autophagy in skeletal muscle: implications for Pompe disease

Affiliations
Review

Autophagy in skeletal muscle: implications for Pompe disease

L Shea et al. Int J Clin Pharmacol Ther. 2009.

Abstract

Pompe disease is caused by an inherited deficiency of acid a-glucosidase (GAA), a lysosomal enzyme that catalyzes the breakdown of glycogen to glucose. In the absence of GAA, enlarged, glycogen-laden lysosomes accumulate in multiple tissues, although the major clinical manifestations are seen in cardiac and skeletal muscle. For many years, it was believed that the rupture of glycogen-filled lysosomes was the major cause of the profound muscle damage observed in patients with Pompe disease. Here, we present evidence that a failure of productive autophagy in muscle tissue contributes strongly to disease pathology in both patients with Pompe disease and GAA-knockout mice. In the GAA-knockout mouse model, progressive accumulation of autophagic vesicles is restricted to Type II-rich muscle fibers. Not only does this build-up of autophagosomes disrupt the contractile apparatus in the muscle fibers, it also interferes with enzyme replacement therapy by acting as a sink for the recombinant enzyme and preventing its efficient delivery to the lysosomes. Our data indicate that a re-examination of the presumed pathological mechanism in Pompe disease is necessary, and suggest that successful treatment of patients with Pompe disease will require consideration of the dramatic failure of autophagy that occurs in this disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Electron micrographs of (a) Type I-rich (soleus) muscle and (b) Type II-rich (gastrocnemius) muscle from a 5-month-old acid α-glucosidase knockout mouse.
Figure 2
Figure 2
Differential interference contrast microscopy images of unstained single muscle fibers from (a) 6-month-old wild-type and (b) acid α-glucosidase (GAA)-knockout mice. Centrally located autophagic accumulation is clearly visible throughout the length of the fiber from the GAA-knockout mouse. Bar, 20 μm.
Figure 3
Figure 3
Western blot analysis of microtubule-associated protein 1 light chain 3 (LC3) in skeletal muscle derived from wild-type (WT) and acid α-glucosidase (GAA)-knockout (KO) mice. In KO mice, both Type I-rich (soleus) muscle and Type II-rich (gastrocnemius) muscle showed higher levels of LC3-I and LC3-II compared with WT. Muscle biopsies were taken from 5-month-old mice.
Figure 4
Figure 4
Toluidin blue-stained biopsies taken from Type-II rich extensor digitorum longus muscle of acid α-glucosidase knockout mice. a: 0.5-month-old mouse, b: 1-month-old mouse, c: 23-month-old mouse.

Similar articles

Cited by

References

    1. Amalfitano A, Bengur AR, Morse RP, Majure JM, Case LE, Veerling DL, et al. Recombinant human acid α-glucosidase enzyme therapy for infantile glycogen storage disease Type II: results of a Phase I/II clinical trial. Genet Med. 2001;3:132–138. - PubMed
    1. Berg TO, Fengsrud M, Stromhaug PE, Berg T, Seglen PO. Isolation and characterization of rat liver amphisomes. Evidence for fusion of autophagosomes with both early and late endosomes. J Biol Chem. 1998;273:21883–21892. - PubMed
    1. Fukuda T, Ahearn M, Roberts A, Mattaliano RJ, Zaal K, Ralston E, et al. Autophagy and mistargeting of therapeutic enzyme in skeletal muscle in Pompe disease. Mol Ther. 2006a;14:831–819. - PMC - PubMed
    1. Fukuda T, Ewan L, Bauer M, Mattaliano RJ, Zaal K, Ralston E, et al. Dysfunction of endocytic and autophagic pathways in a lysosomal storage disease. Ann Neurol. 2006b;59:700–708. - PubMed
    1. Fukuda T, Roberts A, Ahearn M, Zaal K, Ralston E, Plotz PH, et al. Autophagy and lysosomes in Pompe disease. Autophagy. 2006c;2:318–320. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources